Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Pappajohn currently holds 1,132,925 shares of CANCER GENETICS, INC (CGIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Pappajohn has been a net seller of CGIX stock. They have purchased $11.0M and sold $11.5M worth of shares.
John Pappajohn's most recent insider trade was on Jul 16, 2019, when they sold 1,132,925 shares at $0.00 per share.
John Pappajohn serves as Executive at CANCER GENETICS, INC (CGIX). They have executed 179 insider transactions totaling $22.5M over their tenure at the company.
John Pappajohn holds the position of Executive at CANCER GENETICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John Pappajohn has shown a selling trading pattern, with $11.0M in total purchases and $11.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Pappajohn was on Jun 12, 2017, when they purchased $375.0K worth of CGIX shares. This transaction involved 100,000 shares at $3.75 per share.
John Pappajohn currently owns 1,132,925 shares of CANCER GENETICS, INC (CGIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Pappajohn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Pappajohn has 179 Form 4 filings on record as an insider at CANCER GENETICS, INC.
Set alerts for John Pappajohn and 40,000+ other insiders.